Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Standard_BioTools
|
| gptkbp:acquisitionYear |
2024
|
| gptkbp:CEO |
gptkb:Adam_Taich
|
| gptkbp:collaboratesWith |
academic institutions
pharmaceutical companies |
| gptkbp:foundedYear |
2000
|
| gptkbp:founder |
gptkb:Larry_Gold
|
| gptkbp:headquartersLocation |
gptkb:Boulder,_Colorado,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
SomaLogic
|
| gptkbp:industry |
gptkb:biotechnology
proteomics |
| gptkbp:notableProduct |
gptkb:SomaScan_Platform
|
| gptkbp:numberOfEmployees |
~400 (as of 2023)
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:specializesIn |
gptkb:SOMAmer_technology
clinical diagnostics protein biomarker discovery |
| gptkbp:stockExchange |
gptkb:Nasdaq
|
| gptkbp:stockSymbol |
gptkb:SLGC
|
| gptkbp:website |
https://www.somalogic.com/
|
| gptkbp:bfsParent |
gptkb:SOMAmer_technology
gptkb:SomaScan_Assay gptkb:Casdin_Capital gptkb:Brook_Byers gptkb:Charles_R._Cantor |
| gptkbp:bfsLayer |
6
|